Covered recipient · General Payments record
WILLIAM FADER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$478.78
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $225.45 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $82.34 | 4 |
| Novo Nordisk AS | $44.03 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $32.82 | 2 |
| Lilly USA, LLC | $25.90 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.91 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $18.83 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146760759 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.99 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146763594 | CMS |
| Indivior Inc. | $13.29 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144551639 | CMS |
| Indivior Inc. | $22.35 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144551641 | CMS |
| Indivior Inc. | $21.27 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144551643 | CMS |
| Indivior Inc. | $25.43 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144551645 | CMS |
| Lilly USA, LLC | $25.90 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135993542 | CMS |
| Novo Nordisk Inc | $23.66 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100249504 | CMS |
| Novo Nordisk Inc | $20.37 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100415076 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.91 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119068638 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.45 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144641030 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.